Nutrient Profiling and Bio-efficacy of Wheat-Barley Composite Flour in Type-2 Diabetes a in Randomized Control Clinical Trial
Nutrient Profiling and Bio-efficacy of an Economic and Palatable Composite Flour for Type-2 Diabetes and Associated Metabolic Abnormalities in Open Label Randomized Control Clinical Trial
Sponsor: University of Veterinary and Animal Sciences, Lahore - Pakistan
Listed as NCT04658264, this PHASE1 trial focuses on Barley/Wheat Composite Flour in Type-2 Diabetes and remains ongoing. Sponsored by University of Veterinary and Animal Sciences, Lahore - Pakistan, it has been updated 4 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1
Status: Unknown Status → Unknown
-
Jan 2023 — Jul 2024 [monthly]
Unknown Status PHASE1
Status: Not Yet Recruiting → Unknown Status
-
Jan 2021 — Jan 2023 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Veterinary and Animal Sciences, Lahore - Pakistan
For direct contact, visit the study record on ClinicalTrials.gov .